Gemcitabine plus Nab-paclitaxel for locally advanced unresectable pancreatic cancer. (April 2016) - Saito, T.; Toyoki, Y.; Ishido, K.; Kudo, D.; Kimura, N.; Wakiya, T.; Kagiya, T.; Hakamada, K.